Interplay between mTOR and PRMT5 has already been identified in different cell types, including T-lymphocytes B-cell lymphoma and glioblastoma (Holmes et al., 2019; Webb et al., 2019; Zhu et al., 2019). Here, PRMT5 is linked to B-cell non-Hodgkin lymphoma.